Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10000 participants
OBSERVATIONAL
2013-09-30
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolomics Predict Therapy Response
NCT03736993
20K Distributed Learning Challenge
NCT03564457
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
NCT01936571
A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
NCT05732974
Radiomics: a Study of Outcome in Lung Cancer
NCT01302626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective collection
Retrospective collection of data from included lung cancer patients.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liverpool Cancer Therapy Centre
OTHER_GOV
Macarthur Cancer Therapy Centre, Liverpool
OTHER
Ingham Institute Hospital, Liverpool
UNKNOWN
NSW, Australia
UNKNOWN
Maastricht Radiation Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andre Dekker, Dr
Role: PRINCIPAL_INVESTIGATOR
Maastro Clinic, The Netherlands
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MAASTRO clinic
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rapid learning lung cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.